	US 12,419,917 B2
	Compositions and methods for treatment of conditions using fractionated honey
Gavin Mark Gear, Monterey, CA (US); and Roger Brett Edmonds, Auckland (NZ)
Assigned to NDAL MFG INC, Monterey, CA (US)
Filed by NDAL MFG INC, Monterey, CA (US)
Filed on Apr. 20, 2022, as Appl. No. 17/725,377.
Claims priority of provisional application 63/304,209, filed on Jan. 28, 2022.
Claims priority of provisional application 63/178,973, filed on Apr. 23, 2021.
Prior Publication US 2022/0339206 A1, Oct. 27, 2022
Int. Cl. A61K 35/644 (2015.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61P 31/00 (2006.01)

CPC A61K 35/644 (2013.01) [A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/22 (2013.01); A61P 31/00 (2018.01)]

11 Claims

1. A method of treating a human suffering from an infection or disease caused by a pathogen, the method comprising:

administering to the human in need thereof a therapeutically effective amount of a composition comprising a fractionated honey,

wherein the fractionated honey is Leptospermum scoparium honey and is free of all DNA markers for Leptospermum scoparium pollen;

wherein the fractionated honey does not undergo yeast fermentation associated with honey at moisture contents greater than 19% water by weight; and

wherein the composition comprises between 19 weight % and 99 weight % water, and has a water activity of between 0.85 and 1.0, and a pH between 3 and 4.5.